Skip to main content
. 2017 May 11;37(3):BSR20170286. doi: 10.1042/BSR20170286

Table 1. Clinical studies of the weight-loss effects of capsaicin.

Treatments Year Country Study design Subjects included Baseline BMI Sample size Age (years) Outcomes Adverse events Potential mechanism Reference
Capsinoids (6 mg per day for 12 weeks) 2009 U.S.A. Double-blind, randomized, placebo-controlled trial Overweight individuals 30.6 ± 2.4 N=80 42 ± 8 Body weight decreased 0.92 kg; abdominal fat decreased 1.11% None Increase in fat oxidation and genetic polymorphisms Snitker et al. [35]
Red pepper (capsaicin 10 g single meal) 1999 Canada Prospective study Healthy individuals 25.3 ± 4.7 N=23 25.8 ± 2.8 Decreased appetite None Increase in sympathetic nervous system activity Yoshioka et al. [40]
Capsinoids (10 mg/kg per day for 4 weeks) 2007 Japan Double-blind, randomized, placebo-controlled trial Men and postmenopausal women >23 N=48 30–65 Body weight tended to decrease during the 2- to 4-week period None Increased VO2, energy expenditure, and fat oxidation Inoue et al. [37]
Capsaicin (135 mg per day for 3 months) 2003 Netherlands Randomized double-blind placebo-controlled study Moderately overweight subjects 29.3 ± 2.5 N=140 18–60 Significant increase in resting energy expenditure None More sustained fat oxidation Lejeune et al. [36]
Capsinoids (9 mg per day for 8 weeks) 2016 Japan Randomized double-blind placebo-controlled study College students 21.4 ± 1.8 N=20 20.7 ± 1.2 Increased brown adipose tissue (BAT) density None Increased BAT activity Nirengi et al. [43]